Source: Virtual Congress 2021 – Challenges and advances in the diagnosis and clinical management of tuberculosis



Rating:

Share or cite this content

Citations should be made in the following way:
K. Manalan (London, United Kingdom), I. Testi (London, United Kingdom), B. Dixit (London, United Kingdom), Y. Payadachee (London, United Kingdom), C. Sethi (London, United Kingdom), L. Martin (London, United Kingdom), G. Russell (London, United Kingdom), P. Addison (London, United Kingdom), C. Pavesio (London, United Kingdom), H. Petrushkin (London, United Kingdom), R. Akshikar (London, United Kingdom), O. Kon (London, United Kingdom). Management of ocular tuberculosis(OTB): The role of CT and Positron Emission Tomography(PET) imaging. 1042

Member's Comments

No comment yet.

Related content which might interest you: A totally Positron Emission Tomography (PET) negative lung cancer Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons Year: 2017 Incidental findings in Positron Emission Tomography - Computed Tomography for Lung Cancer Assessment Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018 Positron emission tomography in sarcoidosis Source: Eur Respir J 2005; 26: Suppl. 49, 212s Year: 2005 Positron emission tomography findings in round atelectasis Source: Annual Congress 2009 - Old and new: technique and pathology Year: 2009 Positron emission tomography (PET) and computed tomography (CT) in the assessment of the mediastinum for patients with presumed or established lung cancer Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs Year: 2008 Imaging the inflammatory activity of sarcoidosis Source: Eur Respir J 2013; 41: 743-751 Year: 2013 (18)F-FDG positron emission tomography/computed tomography and pulmonary function in sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Positron emission tomography in the diagnostic work-up of screening-detected lung nodules Source: Eur Respir J 2015; 45: 501-510 Year: 2015 Advances in chest imagery Source: Annual Congress 2006 - Clinical year in review Year: 2006 Positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) for evaluation of indeterminate adrenal mass in patients with lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002 Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 227s Year: 2001 Fluorine-18-fluorodeoxyglucose positron emission tomography (18F-FDGPET) may be useful in the management of sarcoidosis Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer Source: Annual Congress 2008 - New imaging modalities in the staging of lung cancer Year: 2008 Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration Source: Eur Respir J 2009; 33: 201-212 Year: 2009 Positron emission tomography (PET) using 18F-fluorodeoxyglucose (18FDG) can detect radiographically ”occult“ lung cancer (ROLC) in the central airways Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Imaging can replace mediastinoscopy: PRO Source: Annual Congress 2005 - Lung cancer staging: not as simple as it seems? Year: 2005 Use of Ventilation-Perfusion Single-Photon Emission Computed Tomography (VQ SPECT) to Select the Target Lobe for Endobronchial Valves Lung Volume Reduction (EBV-LVR) Source: International Congress 2018 – Interventional pulmonology highlights in 2018: ELVR, TLD and BT Year: 2018 Nontraumatic chylothorax and previous cancer: a role for positron emission tomography? Source: Eur Respir J 2005; 26: 749-750 Year: 2005